» Articles » PMID: 26664067

Assessment of Adverse Drug Reactions Based on Spontaneous Signals at Secondary Care Public Hospital

Overview
Specialty Pharmacy
Date 2015 Dec 15
PMID 26664067
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Adverse drug reactions are considered to be among the leading causes of morbidity and mortality. Approximately 5-25% of hospital admissions are due to adverse drug reactions and 6-15% of hospitalized patients experience serious adverse drug reactions, causing significant prolongation of hospital stay. Thus this study was aimed at determining adverse drug reactions by conducting spontaneous reporting in secondary care Govt. District Head Quarters Hospital at Ooty. A prospective Spontaneous Adverse Drug Reaction reporting study was conducted over a period of 12 months from July 2012 to June 2013. The assessment, categorization, causality, severity and preventability were assessed using standard criteria. A total of 47 suspected adverse drug reactions were reported during the study period. Over all incidences was 1.29% among the study population. Antibiotics (31.91%) were the class of drug most commonly involved, while ciprofloxacin (14.89%) was the most frequently reported. Type H (Hypersensitivity) reactions (51.06%) accounted for majority of the reports and a greater share of the adverse drug reactions are probable (89.36%) based on causality assessment. Mild reactions accounted 82.97% based on modified Hartwig and Siegel severity scale. In 76.59% of the reports, the reaction was considered to be preventable based on Schumock and Thornton preventability scale. The implementation of monitoring based on spontaneous reporting will be useful for the detection and evaluation is associated with increase in morbidity and duration of hospitalization. This study also has established the vital role of clinical pharmacist in the adverse drug reaction monitoring program.

Citing Articles

Evaluation of the Effectiveness of the Adverse Drug Reaction Alert Card System in Preventing the Recurrence of Adverse Drug Reactions.

Mulkalwar S, Chitale S, Dandage P, Bapat S, Tilak A, Patil S Cureus. 2024; 16(7):e64653.

PMID: 39149672 PMC: 11326754. DOI: 10.7759/cureus.64653.


Exploration and Evaluation of Adverse Drug Reactions Documented in a Tertiary-Care Hospital in Chennai: An In-Depth Retrospective Observational Study.

Selva P, Durairajan S Cureus. 2024; 16(5):e60977.

PMID: 38915954 PMC: 11194127. DOI: 10.7759/cureus.60977.


[A study of incidence and clinical characteristics of adverse drug reactions in hospitalized patients.].

Esteban Jimenez O, Navarro Peman C, Gonzalez Rubio F, Lanuza Gimenez F, Montesa Lou C Rev Esp Salud Publica. 2017; 91.

PMID: 29269726 PMC: 11587308.


Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability.

Ithnin M, Mohd Rani M, Abd Latif Z, Kani P, Syaiful A, Nor Aripin K JMIR Mhealth Uhealth. 2017; 5(5):e78.

PMID: 28559222 PMC: 5470006. DOI: 10.2196/mhealth.6261.

References
1.
Chan A, Lee H, Ho C, Cham T, Lin S . Cost evaluation of adverse drug reactions in hospitalized patients in Taiwan: A prospective, descriptive, observational study. Curr Ther Res Clin Exp. 2014; 69(2):118-29. PMC: 3969903. DOI: 10.1016/j.curtheres.2008.04.005. View

2.
Patel K, Kedia M, Bajpai D, Mehta S, Kshirsagar N, Gogtay N . Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007; 7:8. PMC: 1963321. DOI: 10.1186/1472-6904-7-8. View

3.
Schumock G, Thornton J . Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992; 27(6):538. View

4.
van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L . Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004; 13(7):457-64. DOI: 10.1002/pds.897. View

5.
Arulmani R, Rajendran S, Suresh B . Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2007; 65(2):210-6. PMC: 2291214. DOI: 10.1111/j.1365-2125.2007.02993.x. View